 |
|
|
|
|
|
|
|
|
|
|
|
1 to 13 of 13 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Hasegawa T. on NEWS: Breathe Deep—Nighttime Oxygen Loss Linked to Dementia, This report should be supported by the pathogenic confirmation of Alzheimer’s disease, but it is... 18 Aug 2011.
|
|
|
 |
|
|
Hasegawa T. on LIVE DISCUSSION: Reimagining Alzheimer's Disease—Time for Bright New Ideas?
, Yes, aging is the strongest risk factor, but how does age induce Alzheimer's disease?
We... 10 May 2011.
|
|
|
|
|
|
Hasegawa T. on PAPER: Arsenault D. et al., 2011, Yes, this is a very nice, suggestive paper. It is especially interesting that DHA has no effect... 22 Mar 2011.
|
|
|
|
|
|
Hasegawa T. on PAPER: Gandy S. et al., 2010, It is always my pleasure to read such a wonderful paper. However, I always wonder why the... 21 Oct 2010.
|
|
|
|
|
|
Hasegawa T. on NEWS: Brain Aβ Patterns Linked to Brain Energy Metabolism, Drs. Raichle and Mintun have reported a very interesting phenomenon, that is, amyloid deposition... 27 Sep 2010.
|
|
|
|
|
|
Hasegawa T. on PAPER: Soscia SJ. et al., 2010, A surprising report has been published in PLoS ONE (1). Amyloid-β is now thought to be an... 2 Apr 2010.
|
|
|
|
|
|
Hasegawa T. on PAPER: Hasegawa T. et al., 2010, A Chinese article (1) has previously reported that homocysteic acid (HA) levels in blood were... 9 Mar 2010.
|
|
|
|
|
|
Hasegawa T. on PAPER: Hasegawa T. et al., 2010, Recently, JAMA (1) reported that the Phase 3 clinical trial of Tarenflurbil, aka flurizan, a... 13 Feb 2010.
|
|
|
|
|
|
Hasegawa T. on NEWS: Paper Alert—Phase 3 Tarenflurbil Data Published, Tarenflurbil, a γ-secretase modulator, failed in Phase 3 trial. Recent clinical failures of... 22 Dec 2009.
|
|
|
|
|
|
Hasegawa T. on PAPER: Zhang C. et al., 2009, Dr. Saura discussed that FAD presenilin mutation showed neurodegeneration in humans, but not in... 10 Sep 2009.
|
|
|
|
|
|
Hasegawa T. on NEWS: Mitochondria Sag Early in AD Mouse Model, The authors have observed an interesting pathogenic change in the 3xTg-AD female brain in that a... 25 Aug 2009.
|
|
|
|
|
|
Hasegawa T. on NEWS: The B Side—Vitamins Won’t Sharpen AD Brains, Trial Suggests, Our findings in B6-deficient diet are based on the controversial situation of homocysteine risk... 13 Jan 2009.
|
|
|
|
|
|
Hasegawa T. on PAPER: McMahon JA. et al., 2006, It is known that homocysteine is a risk factor for Alzheimer disease, but recently it has been... 17 May 2007.
|
|
|
|
|
|
|
1 to 13 of 13 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
